Cefuzonam
- Level
- Commodity
- Parent
- 51283700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51283710This classification denotes a cephalosporin antibiotic with the molecular formula C16H15N7O5S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 860MT00T7T, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-((1,2,3-thiadiazol-5-ylthio)methyl)-, (6r-(6alpha,7beta(z)))- but generally known as cefuzonam, which bears US NIH Compound Identifier 6336505. European Medicines Agency schedules Cefuzonam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07434MIG. The term CEFUZONAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). CEFUZONAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefuzonam under HS 29419000 and SITC 54139. As of Q4 2014, CEFUZONAM remains the US FDA Preferred Term for this commodity. Cefuzonam bears US NLM identifiers UMLS ID C0055017 and NCI Concept Code C76179. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N\OC)C2NC(SC2)N)C(=C(C1)CSC1SNNC1)C(=O)O.
Same parent
Under 51283700 · 28Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.